Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Nov 10;4(3):484-486.
doi: 10.1016/j.ekir.2018.11.001. eCollection 2019 Mar.

Cyclophosphamide-Induced Lung Injury

Affiliations
Case Reports

Cyclophosphamide-Induced Lung Injury

Dan Pugh et al. Kidney Int Rep. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a) Initial computed tomogram with mild changes, notably extensive emphysema, and bi-basal peripheral–ground-glass changes. (b) Computed tomogram from 4 months later (after initiation of cyclophosphamide), with severe centrilobar and paraseptal emphysema with new inflammatory changes. (c) Improvement in the changes seen in (b), 3 months after cyclophosphamide withdrawal.
Figure 2
Figure 2
(a) X-ray taken before cyclophosphamide treatment. (b) X-ray taken during treatment. (c) X-ray taken 2 months after cyclophosphamide was discontinued. The pretreatment X-ray was reported as showing a largely peripheral and basal pattern of fibrosis, which then improved significantly following drug withdrawal.

References

    1. Twohig K.J., Matthay R.A. Pulmonary effects of cytotoxic agents other than bleomycin. Clinics Chest Med. 1990;11:31–54. - PubMed
    1. Malik S.W., Myers J.L., DeRemee R.A., Specks U. Lung toxicity associated with cyclophosphamide use. Two distinct patterns. Am J Resp Crit Care Med. 1996;154:1851–1856. - PubMed
    1. Sampath S., Schultheiss T.E., Wong J. Dose response and factors related to interstitial pneumonitis after bone marrow transplant. Int J Rad Oncol Biol Physics. 2005;63:876–884. - PubMed
    1. Herlyn K., Buckert F., Gross W.L., Reinhold-Keller E. Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany. Rheumatology. 2014;53:882–889. - PubMed
    1. Dhaun N., Saunders A., Bellamy C.O., Gallardo R.M., Manson L., Kluth D.C. Benefits of an expanded use of plasma exchange for anti-neutrophil cytoplasmic antibody-associated vasculitis within a dedicated clinical service. BMC Musculoskel Dis. 2015;16:343. - PMC - PubMed

Publication types

LinkOut - more resources